To further examine T cell priming, we adoptively transferred naive CD8+ OT-I T cells (Extended Data Fig. 3d), which express a transgenic T cell receptor (TCR) specific for OVA, into mice subsequently transplanted with BRAFV600E-OVA tumours. This evidence concerns the gene CD8A and neoplasm.